Skip to main content
Erschienen in:

02.05.2023 | Review Article

Delayed Puberty

verfasst von: Swathi Mohanraj, Hemchand Krishna Prasad

Erschienen in: Indian Journal of Pediatrics | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Testicular volume ≥4 ml and appearance of breast budding are the first signs of puberty. Delayed puberty is diagnosed in the absence of thelarche by 13 y or menarche by 15 y in girls and absence of testicular enlargement by 14 y in boys. Delayed puberty can be due to hypogonadotrophic hypogonadism, hypergonadotrophic hypogonadism or eugonadotrophic eugonadism characterised by low, elevated and normal gonadotrophin levels, respectively. Constitutional Delay of Growth and Puberty (CDGP) and systemic illness should be considered before pathological causes. Assessment of sexual maturity by Tanner’s staging and anthropometric assessment on growth chart is pivotal. Lack of menarche in girls with thelarche suggests structural abnormalities of reproductive tract or disorders of sexual development. Measurement of bone age helps to interpret hormone measurements and decide on timing of pubertal induction. Ultrasound assessment of abdomen gives valuable clues to pubertal onset (in girls) and possible underlying etiology. Karyotyping is mandatory in all girls with delayed puberty and short stature, and delayed menarche and boys with hypergonadotrophic hypogonadism. Gonadotrophin releasing hormone analogue stimulation test may help distinguish hypogonadotrophic hypogonadism from CDGP. Pubertal induction is done with intramuscular testosterone and oral estradiol in boys and girls, respectively. Hormone replacement is begun at low doses and slowly escalated over 2 y to mimic a physiological puberty process. Short course of testosterone for 3 to 6 mo is helpful in adolescent boys with CDGP and psychological distress. Attainment of adult sexual maturity by 18 y is mandatory to rule out disorders of hypothalamic pituitary gonadal axis.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
3.
Zurück zum Zitat Bajpai A. Testicular Disorders. In: Bajpai A, ed. Advanced Pediatric Endocrinology Vol 2, 1st ed. Kanpur: Med E Classes Publications; 2021. p. 195–261. Bajpai A. Testicular Disorders. In: Bajpai A, ed. Advanced Pediatric Endocrinology Vol 2, 1st ed. Kanpur: Med E Classes Publications; 2021. p. 195–261.
4.
Zurück zum Zitat Martin DD, Wit JM, Hochberg Z, et al. The use of bone age in clinical practice - part 1. Horm Res Paediatr. 2011;76:1–9.CrossRefPubMed Martin DD, Wit JM, Hochberg Z, et al. The use of bone age in clinical practice - part 1. Horm Res Paediatr. 2011;76:1–9.CrossRefPubMed
6.
Zurück zum Zitat Marshall WA, Tanner JM. Growth and physiological development during adolescence. Annu Rev Med. 1968;19:283–300.CrossRefPubMed Marshall WA, Tanner JM. Growth and physiological development during adolescence. Annu Rev Med. 1968;19:283–300.CrossRefPubMed
7.
Zurück zum Zitat Gao Y, Du Q, Liu L, Liao Z. Serum inhibin B for differentiating between congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty: a systematic review and meta-analysis. Endocrine. 2021;72:633–43.CrossRefPubMedPubMedCentral Gao Y, Du Q, Liu L, Liao Z. Serum inhibin B for differentiating between congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty: a systematic review and meta-analysis. Endocrine. 2021;72:633–43.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Gilsanz V, Chalfant J, Kalkwarf H, et al. Age at onset of puberty predicts bone mass in young adulthood. J Pediatr. 2011;158:100-5, 105.e1-2. Gilsanz V, Chalfant J, Kalkwarf H, et al. Age at onset of puberty predicts bone mass in young adulthood. J Pediatr. 2011;158:100-5, 105.e1-2.
9.
Zurück zum Zitat Kohva E, Varimo T, Huopio H, et al. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone. Hum Reprod. 2020;35:257–64.CrossRefPubMedPubMedCentral Kohva E, Varimo T, Huopio H, et al. Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone. Hum Reprod. 2020;35:257–64.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre-and peripubertal boys with idiopathic short stature. Horm Res. 2009;71:290–7.PubMed Hero M, Mäkitie O, Kröger H, Nousiainen E, Toiviainen-Salo S, Dunkel L. Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre-and peripubertal boys with idiopathic short stature. Horm Res. 2009;71:290–7.PubMed
11.
Zurück zum Zitat Varimo T, Huopio H, Kariola L, et al. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial. Lancet Child Adolesc Health. 2019;3:109–20.CrossRefPubMed Varimo T, Huopio H, Kariola L, et al. Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial. Lancet Child Adolesc Health. 2019;3:109–20.CrossRefPubMed
12.
Zurück zum Zitat Jakkidi LR. Delayed Puberty. In: Khadilkar V, editor. IAP Text book of Pediatric Endocrinology. 1st ed. New Delhi: Jaypee; 2019. p. 130–87. Jakkidi LR. Delayed Puberty. In: Khadilkar V, editor. IAP Text book of Pediatric Endocrinology. 1st ed. New Delhi: Jaypee; 2019. p. 130–87.
13.
Zurück zum Zitat Sultan C, Gaspari L, Maimoun L, Kalfa N, Paris F. Disorders of puberty. Best Pract Res Clin Obstet Gynaecol. 2018;48:62–89.CrossRefPubMed Sultan C, Gaspari L, Maimoun L, Kalfa N, Paris F. Disorders of puberty. Best Pract Res Clin Obstet Gynaecol. 2018;48:62–89.CrossRefPubMed
14.
Zurück zum Zitat Traggiai C, Stanhope R. Delayed puberty. Best Pract Res Clin Endocrinol Metab. 2002;16:139–51.CrossRefPubMed Traggiai C, Stanhope R. Delayed puberty. Best Pract Res Clin Endocrinol Metab. 2002;16:139–51.CrossRefPubMed
15.
Zurück zum Zitat Khadilkar VV, Khadilkar AV, Choudhury P, Agarwal KN, Ugra D, Shah NK. IAP growth monitoring guidelines for children from birth to 18 years. Indian Pediatr. 2007;44:187–97.PubMed Khadilkar VV, Khadilkar AV, Choudhury P, Agarwal KN, Ugra D, Shah NK. IAP growth monitoring guidelines for children from birth to 18 years. Indian Pediatr. 2007;44:187–97.PubMed
16.
Zurück zum Zitat Sinha S, Shah D, Osmond C, Fall CHD, Bhargava SK, Sachdev HS. Intergenerational change in anthropometry of children and adolescents in the New Delhi Birth Cohort. Int J Epidemiol. 2022;51:291–302.CrossRefPubMed Sinha S, Shah D, Osmond C, Fall CHD, Bhargava SK, Sachdev HS. Intergenerational change in anthropometry of children and adolescents in the New Delhi Birth Cohort. Int J Epidemiol. 2022;51:291–302.CrossRefPubMed
17.
Zurück zum Zitat Lohiya N, Jahagirdar R, Deshpande R, Goyal A. Sexual maturity assessment in Indian children-a study from western India. J Pediatr Endocrinol Metab. 2021;34:567–72.CrossRefPubMed Lohiya N, Jahagirdar R, Deshpande R, Goyal A. Sexual maturity assessment in Indian children-a study from western India. J Pediatr Endocrinol Metab. 2021;34:567–72.CrossRefPubMed
18.
Zurück zum Zitat Khadgawat R, Marwaha RK, Mehan N, et al. Age of onset of puberty in apparently healthy school girls from Northern India. Indian Pediatr. 2016;53:383–7.CrossRefPubMed Khadgawat R, Marwaha RK, Mehan N, et al. Age of onset of puberty in apparently healthy school girls from Northern India. Indian Pediatr. 2016;53:383–7.CrossRefPubMed
19.
Zurück zum Zitat Surana V, Dabas A, Khadgawat R, et al. Pubertal onset in apparently healthy Indian boys and impact of obesity. Indian J Endocrinol Metab. 2017;21:434–8.CrossRefPubMedPubMedCentral Surana V, Dabas A, Khadgawat R, et al. Pubertal onset in apparently healthy Indian boys and impact of obesity. Indian J Endocrinol Metab. 2017;21:434–8.CrossRefPubMedPubMedCentral
20.
21.
22.
Zurück zum Zitat Bajpai A, Mehta S. Approach to Delayed Puberty. In: Bajpai A, ed. Practical Pediatric Endocrinology, 1st ed. New Delhi. Indian Journal of Pediatrics; 2021. p.153–68. Bajpai A, Mehta S. Approach to Delayed Puberty. In: Bajpai A, ed. Practical Pediatric Endocrinology, 1st ed. New Delhi. Indian Journal of Pediatrics; 2021. p.153–68.
23.
Zurück zum Zitat Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87:1613–20.CrossRefPubMed Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87:1613–20.CrossRefPubMed
24.
Zurück zum Zitat Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol. 1981;140:371–80.CrossRefPubMed Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol. 1981;140:371–80.CrossRefPubMed
25.
Zurück zum Zitat Zahra F, Ahsan T, Lal Rehman U, Jabeen R. Clinical spectrum and causes of delayed puberty among patients presenting to the endocrine clinic at Jinnah Postgraduate Medical Centre. Cureus. 2022;14:e21574.PubMedPubMedCentral Zahra F, Ahsan T, Lal Rehman U, Jabeen R. Clinical spectrum and causes of delayed puberty among patients presenting to the endocrine clinic at Jinnah Postgraduate Medical Centre. Cureus. 2022;14:e21574.PubMedPubMedCentral
26.
Zurück zum Zitat Selvaraj A, Prasad HK, Narayanasamy K, Thiagarajan A, Nedunchelian K. Clinical profile of adolescents with delayed puberty. Indian Pediatr. 2021;58:684–5.CrossRefPubMed Selvaraj A, Prasad HK, Narayanasamy K, Thiagarajan A, Nedunchelian K. Clinical profile of adolescents with delayed puberty. Indian Pediatr. 2021;58:684–5.CrossRefPubMed
27.
Zurück zum Zitat Bhakhri BK, Prasad MS, Choudhary IP, Biswas K. Delayed puberty: experience of a tertiary care centre in India. Ann Trop Paediatr. 2010;30:205–12.CrossRefPubMed Bhakhri BK, Prasad MS, Choudhary IP, Biswas K. Delayed puberty: experience of a tertiary care centre in India. Ann Trop Paediatr. 2010;30:205–12.CrossRefPubMed
28.
Zurück zum Zitat Stanhope R, Preece MA. Management of constitutional delay of growth and puberty. Arch Disease Child. 1988;63:1104–10.CrossRef Stanhope R, Preece MA. Management of constitutional delay of growth and puberty. Arch Disease Child. 1988;63:1104–10.CrossRef
29.
Zurück zum Zitat Khadilkar V, Yadav S, Agrawal KK, et al. Indian Academy of Pediatrics Growth Charts Committee. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr. 2015; 52:47–55. Khadilkar V, Yadav S, Agrawal KK, et al. Indian Academy of Pediatrics Growth Charts Committee. Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children. Indian Pediatr2015; 52:47–55.
30.
Zurück zum Zitat Khadilkar VV, Karguppikar MB, Ekbote VH, Khadilkar AV. Turner syndrome growth charts: a Western India experience. Indian J Endocrinol Metab. 2020;24:333–7.CrossRefPubMedPubMedCentral Khadilkar VV, Karguppikar MB, Ekbote VH, Khadilkar AV. Turner syndrome growth charts: a Western India experience. Indian J Endocrinol Metab. 2020;24:333–7.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Khadilkar V, Khadilkar A, Arya A, et al. Height velocity percentiles in Indian children aged 5–17 years. Indian Pediatr. 2019;56:23–8.CrossRefPubMed Khadilkar V, Khadilkar A, Arya A, et al. Height velocity percentiles in Indian children aged 5–17 years. Indian Pediatr. 2019;56:23–8.CrossRefPubMed
32.
Zurück zum Zitat Khadilkar VV, Khadilkar AV, Kinare AS, Tapasvi HS, Deshpande SS, Maskati GB. Ovarian and uterine ultrasonography in healthy girls between birth to 18 years. Indian Pediatr. 2006;43:625–30.PubMed Khadilkar VV, Khadilkar AV, Kinare AS, Tapasvi HS, Deshpande SS, Maskati GB. Ovarian and uterine ultrasonography in healthy girls between birth to 18 years. Indian Pediatr. 2006;43:625–30.PubMed
33.
Zurück zum Zitat Dixit M, Jaiswal V, Usmani Y, Chaudhary R. Uterine and ovarian parameters in healthy North Indian girls from 5 to 16 years by ultrasonography. Pediatr Endocrinol Diabetes Metab. 2021;27:37–41.CrossRefPubMed Dixit M, Jaiswal V, Usmani Y, Chaudhary R. Uterine and ovarian parameters in healthy North Indian girls from 5 to 16 years by ultrasonography. Pediatr Endocrinol Diabetes Metab. 2021;27:37–41.CrossRefPubMed
34.
Zurück zum Zitat Bajpai A. Ovarian Disorders. In: Bajpai A, ed. Advanced Pediatric Endocrinology Vol 2, 1st ed. Kanpur: Med E Classes Publications; 2021. p. 109–94. Bajpai A. Ovarian Disorders. In: Bajpai A, ed. Advanced Pediatric Endocrinology Vol 2, 1st ed. Kanpur: Med E Classes Publications; 2021. p. 109–94.
35.
Zurück zum Zitat Prasad HK, Khadilkar VV, Jahagirdar R, Khadilkar AV, Lalwani SK. Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders. Indian J Endocrinol Metab. 2012;16:400–5.CrossRefPubMedPubMedCentral Prasad HK, Khadilkar VV, Jahagirdar R, Khadilkar AV, Lalwani SK. Evaluation of GnRH analogue testing in diagnosis and management of children with pubertal disorders. Indian J Endocrinol Metab. 2012;16:400–5.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Bajpai A. Precocious Puberty. In: Desai MP, Bhatia V, Menon PS, editors. Pediatric Endocrine Disorders. 1st ed. Hyderabad: Orient Longman; 2001. p. 217–41. Bajpai A. Precocious Puberty. In: Desai MP, Bhatia V, Menon PS, editors. Pediatric Endocrine Disorders. 1st ed. Hyderabad: Orient Longman; 2001. p. 217–41.
37.
Zurück zum Zitat Young J, Xu C, Papadakis GE, et al. Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev. 2019;40:669–710.CrossRefPubMed Young J, Xu C, Papadakis GE, et al. Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev. 2019;40:669–710.CrossRefPubMed
38.
Zurück zum Zitat Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547–64.CrossRefPubMed Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547–64.CrossRefPubMed
39.
Zurück zum Zitat Zacharin M, Sabin MA, Nair VV, Dabadghao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836–42.CrossRefPubMed Zacharin M, Sabin MA, Nair VV, Dabadghao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836–42.CrossRefPubMed
Metadaten
Titel
Delayed Puberty
verfasst von
Swathi Mohanraj
Hemchand Krishna Prasad
Publikationsdatum
02.05.2023
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 6/2023
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-023-04577-x

Neu im Fachgebiet Pädiatrie

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Kann man Gestationsdiabetes mit oralen Antidiabetika behandeln?

Der Wunsch, Frauen mit Gestationsdiabetes eine orale Erstlinientherapie anbieten zu können, bleibt auch vorläufig ein Wunsch: Eine orale Stufentherapie hat sich in einer randomisierten Studie nicht als gleichwertig zu einer Insulintherapie erwiesen. 

Frühwarnzeichen für multiple Sklerose bei Kindern und Jugendlichen

Ein Forschungsteam aus Deutschland und Kanada hat eine Reihe metabolischer, okulärer, muskuloskelettaler, gastrointestinaler und kardiovaskulärer Symptome identifiziert, die bei Kindern und Jugendlichen der Diagnose einer multiplen Sklerose (MS) vorausgehen können.

Harnwegsinfekte: Was taugt die antibiotische Kurzzeittherapie bei Kindern?

In einer aktuellen Metaanalyse wurde untersucht, wie erfolgsversprechend eine verkürzte Antibiotikatherapie bei afebrilen Kindern mit Harnwegsinfekten im Vergleich zur Standardtherapie ist. In gewissen Fällen könnte die Kurzzeittherapie ausreichen. 

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.